Controlled γ-ray irradiation of heparin generates oligosaccharides enriched in highly sulfated sequences

Carbohydrate Polymers

Volumn 55, Issue 1, 2004, Pages 101-112

  Bisio, Antonella ^a   Guglieri, Sara ^a   Frigerio, Marta ^a   Torri, Giangiacomo ^a   Vismara, Elena ^b   Cornelli, Umberto ^c   Bensi, Donata ^d   Gonella, Sergio ^d   De Ambrosi, Luigi ^d  

^a Istituto di Ricerche Chimiche e Biochimiche G Ronzoni   (Italy)

^b POLITECNICO DI MILANO   (Italy)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

^d Laboratori Derivati Organici   (Italy)

Author keywords

Irradiation; Heparin oligosaccharides; MALDI TOF; Nuclear magnetic resonance; Scavenger; Sulfation pattern

Indexed keywords

DEPOLYMERIZATION; GAMMA RAYS; GEL PERMEATION CHROMATOGRAPHY; IRRADIATION; MASS SPECTROMETRY; MOLECULAR WEIGHT; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OLIGOMERS;

SULFATION PATTERNS; UNFRACTIONATED HEPARINS (UFH);

POLYSACCHARIDES;

EID: 0347354819     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2003.08.017     Document Type: Article

References (29)

1. Bisio A., De Ambrosi L., Gonella S., Guerrini M., Guglieri S., Maggia G., Torri G. Preserving the original heparin structure of a novel low molecular weight heparin by γ-irradiation. Arzneimittel-Forschung/Drug Research. 51:2001;806-812.
2. Bitter T., Muir H.M. Quantitative determination of uronic acids with m-hydroxydiphenyl. Analytical Biochemistry. 4:1962;330.
3. Capila I., Linhardt R.J. Heparin-protein interaction. Angewandte Chemie. 41:2002;390-412.
4. Casu B. Structure in biological activities of heparin. Advances in Carbohydrate Chemistry and Biochemistry. 43:1985;51-134.
5. Casu B., Lindahl U. Structure and biological interactions of heparin and heparan sulfate. Advances in Carbohydrate Chemistry and Biochemistry. 57:2001;159-208.
6. Casu B., Torri G. Structural characterization of low molecular weight heparins. Seminars in Thrombosis and Hemostasis. 25:(3):1999;17-25.
7. Chuang W.L., McAllister H., Rabenstein D. Hexasaccharides from the istamine-modified depolymerization of porcine intestinal mucosal heparin. Carbohydrate Research. 337:2002;935-945.
8. Dietrich C.P., Tresariol I.L., Toma L., Moraes C.T., Porcionatto M.A., Oliveira F.W., Nader H.B. Structure of heparan sulfate: Identification of variable and constant oligosaccharide domains in eight heparan sulfates of different origin. Cellular and Molecular Biology. 44:1998;417-429.
9. Farmer T.B., Caprioli R.M. Determination of protein-protein interactions by matrix-assisted laser desorption/ionization mass spectrometry. Journal of Mass Spectrometry. 33:1998;697-704.
10. Gambarini A.G., Miyamoto C.A., Lima G.A., Nader H.B., Dietrich C.P. Mitogenic activity of acidic fibroblast growth factor is enhanced by highly sulfated oligosaccharides derived from heparin and heparan sulfate. Molecular and Cellular Biochemistry. 124:1993;121-129.
11. -). International Journal of Chemical Kinetics. 33:2001;539-547.
12. Giese B. Basic principles. Baldwin J.E. Radicals in organic syntheses: Formation of C-C bonds. Vol. 5:1986;4-35 Pergamon Press, Oxford.
13. Gonella, S., De Ambrosi, L., & Vismara, E (2002). European Patent EP02 425142.3.
14. 13C nuclear magnetic resonance spectroscopy for characterization of heparin preparations. Seminars in Thrombosis and Hemostasis. 27:2001;473-482.
15. 2 values in proteins. Journal of Magnetic Resonance. 97:1992;359-375.
16. Leveugle B., Ding W., Laurence F., Dehouck M.P., Scanameo A., Cecchelli R., Fillit H. Heparin oligosaccharides that pass the blood-brain barrier inhibit β-amyloid precursor protein secretion and heparin binding to β-amyloid peptide. Journal of Neurochemistry. 70:1998;737-744.
17. Lindahl U., Kusche-Gulberg M., Kjellen L. Regulated diversity of heparan sulfate. The Journal of Biological Chemistry. 273:1998;24979-24982.
18. Linhardt J.R., Gunay N.S. Production and chemical processing of low molecular weight heparins. Seminars in Thrombosis and Hemostasis. 25:1999;5-16.
19. Maccarana M., Casu B., Lindahl U. Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. The Journal of Biological Chemistry. 268:1993;23898-23905.
20. Moy F.J., Safran M., Seldon A.P., Kitchen D., Böhlen P., Aviezer D., Yayon A., Powers R. Properly oriented heparin-decasaccharide-induced dimers are biologically active form of basic fibroblast growth factor. Biochemistry. 36:1997;4782-4791.
21. Petitou M., Imberty A., Duchaussoy P., Driguez P.A., Ceccato M.L., Gouvernec F., Sizun P., Hérault J.P., Pérez S., Herbert J.M. Experimental proof of the structure of a thrombin-inhibiting heparin molecule. Chemistry - A European Journal. 7:(4):2001;858-873.
22. Rose M., Dudas B., Cornelli U., Hanin I. Protective effect of the heparin-derived oligosaccharide C3, on AF64A-induced cholinergic lesion in rats. Neurobiology of Aging. 24:2003;481-490.
23. Sudhalter J., Folkman J., Svahn C.M., Bergendal K., D'Amore P.A. Importance of size, sulfation, and anticoagulant activity in the potentiation of acidic fibroblast growth factor by heparin. Journal of Biological Chemistry. 264:1989;6892-6897.
24. Teien A.N., Lie M. Evaluation of an amidolytic heparin assay method: Increased sensitivity by adding purified antithrombin III. Thrombosis Research. 10:1977;399-410.
25. Venkataraman G., Shriver Z., Davis J.C., Sasisekharan R. Fibroblast growth factor 1 and 2 are distinct in oligomerization in the presence of heparin-like glycosaminoglycans. Proceedings of the National Academy of Sciences, USA. 96:1999;1892-1897.
26. Venkataraman G., Shriver Z., Raman R., Sasisekharan R. Sequencing complex polysaccharides. Science. 286:1999;537-542.
27. 2O-saturated aqueous solution. Part II. Quantitative measurements. Mechanism of the radical-induced scission of the glycosidic linkage. Zeitschrift fuer Naturforschung, Teil B: Anorganische Chemie, Organische Chemie. 31B:1976;857-864.
28. Walzer M., Lorens S., Hejna M., Fareed J., Hanin I., Cornelli U., Lee J.M. Low molecular weight glycosaminoglycan blockade of β-amyloid induced neuropathology. European Journal of Pharmacology. 445:2002;211-220.
29. CH coupling constant in heparin derivatives. Carbohydrate Research. 329:2000;239-247.